MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma

@article{CurioniFontecedro2008MAGEC1CT7IT,
  title={MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma},
  author={Alessandra Curioni-Fontecedro and Ashley J Knights and Marianne Tinguely and Natko Nuber and Christof Schneider and Christopher W. Thomson and Lotta von Boehmer and Walter Bossart and Steffen Pahlich and Hartmut Gehring and Holger Moch and Christoph Renner and Alexander K. Knuth and Annette Zippelius},
  journal={Leukemia},
  year={2008},
  volume={22},
  pages={1646-1648}
}
C Stavropoulou, C Sambani, H Rigana, VN Georgakakos, G Voutsinas, KN Manola, GE Pantelias and V Makropoulos, the Hellenic MDS Study Group Laboratory of Health Physics and Environmental Health, NCSR ‘Demokritos’, Athens, Greece; Laboratory of Environmental Mutagenesis and Carcinogenesis, NCSR ‘Demokritos’, Athens, Greece and Department of Occupational and Industrial Hygiene, National School of Public Health, Athens, Greece E-mail: csambani@ipta.demokritos.gr The names and affiliations of the… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma

Clinical & developmental immunology • 2012
View 7 Excerpts
Highly Influenced

Immune therapy in multiple myeloma.

Clinical advances in hematology & oncology : H&O • 2015

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Hematopoietic stem cell transplantation in multiple myeloma.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • 2007

Similar Papers

Loading similar papers…